BioDelivery Sciences International Inc (BDSI) Financials

$5.59

$0.00 (0.00%)

As on 31-Mar-2022 09:30EDT

Market cap

$577 Mln

Revenue (TTM)

$84 Mln

P/E Ratio

6.8

P/B Ratio

3.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Operating Revenue	166.70	156.47	111.39	55.64	61.99	15.55
Cost of Revenue	23.37	24.67	21.59	15.78	19.50	11.26
Gross Profit	143.33	131.81	89.80	39.86	42.49	4.29
Operating Expenses	106.21	98.83	86.06	63.51	71.91	68.22
Operating Profit (EBIT)	37.12	32.98	3.74	-23.65	-29.42	-63.94
Other Income	-0.01	0.00	0.00	-0.01	27.31	0.06
Profit before Tax	29.62	25.96	-15.30	-33.85	-10.69	-67.14
Provision for Tax	-55.24	0.25	0.01	0.01	-15.97	--
Profit after Tax (Net Income)	84.86	25.71	-15.31	-33.87	5.29	-67.14
Minority Interest	--	--	--	--	--	--
Consolidated Profit	84.86	25.71	-15.31	-46.37	5.29	-67.14

Liabilities ($ Mln)	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Shareholder's Funds	187.82	108.23	69.76	29.74	8.88	-17.67
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	54.40	78.67	59.15	57.25	53.08	50.10
Current Liabilities	82.38	53.00	53.99	21.54	26.15	19.89
Total Liabilities	324.60	239.89	182.91	108.53	88.10	52.32

Assets ($ Mln)	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Non-Current Assets	60.98	57.51	65.15	42.49	48.35	9.23
Current Assets	194.89	182.39	117.76	66.04	39.75	43.09
Total Assets	324.60	239.89	182.91	108.53	88.10	52.32
Total Debt*	58.79	78.45	58.57	51.65	47.66	29.27
Net Current Assets	119.69	129.39	63.77	44.50	13.60	--

Cashflow ($ Mln)	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Cash From Operating Activities	41.04	24.98	11.07	-24.11	-32.45	-53.98
Cash Flow from Investing Activities	-6.87	-0.01	-30.76	-2.06	-5.86	-0.41
Cash from Financing Activities	-31.44	22.73	39.76	48.80	27.49	2.85
Net Cash Inflow / Outflow	2.73	47.70	20.07	22.63	-10.82	-51.54

Financials Ratios	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Adjusted EPS ($)	0.82	0.24	-0.18	-0.54	0.09	-1.24
Cash EPS ($)	0.90	0.32	-0.08	-0.44	0.20	-1.24
Adjusted Book Value ($)	1.82	1.03	0.84	0.47	0.16	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	0.40	0.24	0.13	-0.38	-0.58	-1.00
Free Cash Flow per Share ($)	0.39	0.24	0.13	-0.42	-0.68	-1.01

Profitability Ratios	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
ROCE (%)	39.17	16.32	-14.60	-49.11	15.51	-186.03
ROE (%)	57.33	28.89	-30.76	-175.39	-120.28	-957.00
ROA (%)	30.07	12.16	-10.50	-34.45	7.53	-86.58
EBIT Margin (%)	22.27	21.07	3.36	-42.53	-3.40	-411.26
Net Margin (%)	50.91	16.43	-13.74	-60.88	5.92	-430.10
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Revenue Growth (%)	0.07	0.40	1.00	-0.10	2.99	-0.68
EBIT Growth (%)	12.56	781.71	115.81	-1,021.42	96.70	-81.74
Net Profit Growth (%)	230.05	267.99	54.81	-740.81	107.87	-78.22
EPS Growth (%)	2.36	2.33	0.66	-6.70	1.08	-0.72
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Price / Earnings	3.76	17.15	-34.27	-6.88	31.26	-1.41
Price / Book Value	1.70	4.07	7.52	7.84	18.61	-5.35
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	11.92	10.07	41.32	-13.56	47.82	-1.47
Close Price ($)	3.10	4.20	6.32	3.70	2.95	1.75
High Price ($)	4.99	6.39	7.21	4.14	3.60	4.90
Low Price ($)	2.50	2.85	3.52	1.70	1.55	1.50
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Debt to Equity	0.31	0.72	0.84	1.74	5.37	-1.66
Short term debt to equity ratio	0.02	0.72	--	--	5.37	--
Current Ratio	2.37	3.44	2.18	3.07	1.52	2.17
Quick Ratio	2.08	3.11	1.97	2.82	1.29	2.00
Interest Coverage	--	--	--	--	--	--

Operating Efficiency Ratios	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Debtors to sales (%)	34.11	30.77	34.82	24.49	14.28	22.96
Asset Turnover	0.59	0.74	0.76	0.57	0.88	0.20
Receivable days	115.05	101.47	85.94	73.78	36.60	71.15
Inventory Days	321.56	212.91	141.41	133.03	88.61	96.13
Payable days	640.52	117.85	125.78	178.22	284.86	611.16
Cash Conversion Cycle	-203.92	196.53	101.57	28.60	-159.66	-443.87